Cero Therapeutics Files 8-K on Key Agreements
Ticker: CEROW · Form: 8-K · Filed: Jun 30, 2025 · CIK: 1870404
Sentiment: neutral
Topics: material-agreement, equity-sale, corporate-action
TL;DR
Cero Therapeutics filed an 8-K on 6/25/25 covering material agreements and equity sales.
AI Summary
Cero Therapeutics Holdings, Inc. filed an 8-K on June 25, 2025, reporting on a material definitive agreement, unregistered sales of equity securities, and financial statements. The company, formerly Phoenix Biotech Acquisition Corp., is incorporated in Delaware and operates in the biological products sector.
Why It Matters
This filing indicates significant corporate actions and financial reporting by Cero Therapeutics, which could impact investors and stakeholders.
Risk Assessment
Risk Level: medium — The filing involves material definitive agreements and unregistered sales of equity, which can carry inherent risks and require careful investor due diligence.
Key Players & Entities
- CERO THERAPEUTICS HOLDINGS, INC. (company) — Registrant
- PHOENIX BIOTECH ACQUISITION CORP. (company) — Former Company Name
- June 25, 2025 (date) — Date of earliest event reported
FAQ
What type of material definitive agreement was entered into by Cero Therapeutics?
The filing does not specify the nature of the material definitive agreement, only that one was entered into on or before June 25, 2025.
What was the former name of Cero Therapeutics Holdings, Inc.?
The former name of Cero Therapeutics Holdings, Inc. was Phoenix Biotech Acquisition Corp.
When did the name change from Phoenix Biotech Acquisition Corp. to Cero Therapeutics Holdings, Inc. occur?
The date of the name change was June 30, 2021.
What is Cero Therapeutics Holdings, Inc.'s Standard Industrial Classification (SIC) code?
Cero Therapeutics Holdings, Inc.'s SIC code is 2836, which corresponds to Biological Products (No Diagnostic Substances).
What is the SEC file number for Cero Therapeutics Holdings, Inc.?
The SEC file number for Cero Therapeutics Holdings, Inc. is 001-40877.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 30, 2025 regarding CERO THERAPEUTICS HOLDINGS, INC. (CEROW).